RepliCel Life Sciences (TSE:RP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
RepliCel Life Sciences has rescheduled its annual meeting to January 16, 2025, where shareholders will vote on the sale of assets and delisting from the TSX Venture Exchange. The company also announced the resignation of board member Jamie Mackay, who played a crucial role in maintaining company operations during challenging times.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.
